MOUNT LAUREL, N.J., April 3 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ) has announced it has named Alan J. Gold as its new Senior Vice President of Sales and Marketing. Gold will be responsible for client relationships, new business development, and the positioning and promotion of MedQuist.
"We are pleased to have Alan join the MedQuist team," says Peter Masanotti, President and CEO. "He brings an extensive knowledge and an in-depth understanding of healthcare to our business, along with a fine reputation for fostering world-class executive relationships."
Gold has more than 33 years of experience in the healthcare industry. Most recently, he was the Vice President Sales, Managed Services for Siemens Medical Solutions. During his tenure at Siemens, he was instrumental in growing the business, increasing the volume of customers and improving customer satisfaction. Before joining Siemens, Gold held various sales and marketing executive and leadership positions at Shared Medical Systems (SMS), and was heavily involved in the expansion of SMS before it was acquired by Siemens.
Gold holds a bachelor's degree from
MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions - including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors - help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
|SOURCE MedQuist Inc.|
Copyright©2009 PR Newswire.
All rights reserved